Early recognition and referral of hidradenitis suppuritiva (HS) can improve outcomes1,2
Many people with undiagnosed HS seek treatment in emergency rooms or urgent care facilities for immediate symptom relief, such as incision and drainage or pain management. This may be initially effective but because HS is a systemic, chronic condition, recurrence and irreversible disease progression can still occur. Your role referring patients to an HS‑treating dermatology provider helps them receive a diagnosis and begin treatment as early as possible.3-5
Your early referral can support better outcomes
References: 1. Sabat R et al. Nat Rev Dis Primers. 2020;6(1):18. 2. Garg A et al. Am J Med. 2023;136(1):42-53. 3. Alikhan A et al. J Am Acad Dermatol. 2019;81(1):76-90. 4. Kokolakis G et al. Dermatology. 2020;236(5):421-430. 5. Collier EK et al. Int J Dermatol. 2020;59(6):744-747.